Correlation Between Quantitative Longshort and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Quantitative Longshort and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantitative Longshort and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quantitative Longshort Equity and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Quantitative Longshort and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantitative Longshort with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantitative Longshort and Franklin Biotechnology.

Diversification Opportunities for Quantitative Longshort and Franklin Biotechnology

-0.58

Correlation Coefficient

Quantitative Longshort  Franklin Biotechnology

Excellent diversification

The 3 months correlation between Quantitative and Franklin is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Quantitative Longshort Equity and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Quantitative Longshort is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantitative Longshort Equity are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Quantitative Longshort i.e., Quantitative Longshort and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Quantitative Longshort and Franklin Biotechnology

Assuming the 90 days horizon Quantitative Longshort Equity is expected to generate 0.34 times more return on investment than Franklin Biotechnology. However, Quantitative Longshort Equity is 2.94 times less risky than Franklin Biotechnology. It trades about 0.21 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about -0.04 per unit of risk. If you would invest  1,397  in Quantitative Longshort Equity on September 12, 2024 and sell it today you would earn a total of  79.00  from holding Quantitative Longshort Equity or generate 5.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Quantitative Longshort Equity  vs.  Franklin Biotechnology Discove

Quantitative Longshort

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Quantitative Longshort Equity are ranked lower than 16 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Quantitative Longshort is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Quantitative Longshort and Franklin Biotechnology

The main advantage of trading using opposite Quantitative Longshort and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantitative Longshort position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Quantitative Longshort Equity and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.